OrlistAt 96829-58-2 hōʻemi i ka absorlect o ka momona setreity, hopena i ka liloʻana o ke kaumaha
Huahana kikoʻipiop
| Inoa | Orlingt |
| Ka helu helu | 96829-58-2 |
| Mlecular noncula | C29H53no5 |
| Kaupaona molebular | 495.73 |
| Nā helu einecs | 639-755-1 |
| Malting Point | <50 ° C |
| Huakai | 0.976 ± 0.06g / cm3 (wānana) |
| Kūlana paʻa | 2-8 ° C |
| ʻAno | Pauku |
| Kāleka | Keʻokeʻo |
| Acidity chee | (PKA) 14.59 ± 0.23 (wānana) |
Synonyms
(S) -2-forylamino-4-formeyl-pentanocicacid (s) -1 - [(2s, 3-hex Ormyl-l-liusine (1s) -1 - [(2s, 3s)-2-hexyl (synthest (synthesis)
Ka hopena pharmacological
Waiwai
Keʻokeʻo keʻokeʻo keʻokeʻo, aneane insoluble i ka wai, maʻalahi maʻalahi i ka chlorocle,ʻoi aku ka maʻalahi ma mua o 40 ℃ ~ 42 ℃. ʻO kāna molepule he diastereomer e loaʻa ana iʻehā mau kikowaenaʻehā, ma kahi lōʻihi o ka lōʻihi o 529NM,ʻo ia hoʻi ka hopena o ka ethanol
ʻAno hana
ʻO OrlistAt kahi hana lōʻihi a me nā mea e pono ai nā mea i loko o ka inoisestore ʻAʻole hiki iā ia ke hoʻopau i nā mea hoʻonāukiuki i ka momona i nā meaʻai i loko o nā momona momona momona a me ka ho'ēmiʻana i ka momona momona a hōʻemi i ka momona momona. Ma kahi o kekahi, ua loaʻa kekahi mau noiʻi i kēlā orlistat i ka hoʻopiliʻana i ka pili o ka cholesterol-koho-koho-koho.
Nā hōʻike
Ua hōʻikeʻia kēia huahana me kahi papa momona hypocaloric i hōʻikeʻia no ka mālamaʻana i ka nui o ka momona a me nā mea nuiʻole e pili ana i nā mea likeʻole. ʻO kēia huahana ka lōʻihi o ka mālamaʻana i ke kaumaha lōʻihi Hiki i ke alakaʻiʻana i ka orlistat ke hōʻemi i nā mea kūponoʻole e pili ana i nā maʻi pilikia a me ka maʻi o nā maʻi he nui,ʻano maʻi umauma nui, a me nā mea hoʻomehanaʻia.
Hoʻopiʻi i nā lapaʻau lapaʻau
Hiki ke hōʻemi i ka absambtion o nā vitamins A, d a e. hiki iā ia ke hoʻohuiʻia me kēia huahana i ka manawa like. Ināʻoe e lawe ana i ka hoʻomākaukauʻana i nā vitamins a a me e d a me e (e like me kekahi mau multivitamins a iʻole e lawe i kēia huahana a iʻole e lawe ana i kēia huahana. Pono nā poʻe me ka maʻi 2 maʻi 2 e hōʻemi i ka dosing o nāʻoihana hypoglycemic oral (eg, sulfonyluture). Hiki i ka CO-Addition me Cyclosporine hiki i kahi hōʻemi i kahi hōʻemi i nā mea hoʻokūkū plasma o ka hope. E wehewehe paha i ka hoʻohanaʻana o Amiororone
